Drug Shortage Report for MENVEO

Last updated on 2020-02-27 History
Report ID 63919
Drug Identification Number 02347393
Brand name MENVEO
Common or Proper name Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM-197 Conjugate Vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN MENINGOCOCCAL GROUP A OLIGOSACCHARIDE MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE
Strength(s) 5MCG 47MCG 10MCG 5MCG 5MCG
Dosage form(s) SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5's
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-19
Estimated end date
Actual end date 2019-08-28
Shortage status Resolved
Updated date 2020-02-27
Company comments This pack size has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2020-02-27 French Compare
v19 2020-02-27 English Compare
v18 2019-09-06 French Compare
v17 2019-09-06 English Compare
v16 2019-07-10 French Compare
v15 2019-07-10 English Compare
v14 2019-04-10 French Compare
v13 2019-04-10 English Compare
v12 2019-01-11 French Compare
v11 2019-01-11 English Compare
v10 2018-12-20 French Compare
v9 2018-12-20 English Compare
v8 2018-12-20 English Compare
v7 2018-12-14 French Compare
v6 2018-12-14 English Compare
v5 2018-11-12 French Compare
v4 2018-11-12 English Compare
v3 2018-10-12 French Compare
v2 2018-10-12 English Compare
v1 2018-10-12 English Compare

Showing 1 to 20 of 20